COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,639 Articles (22,913 medRxiv, 8,726 bioRxiv)

Most recent first Previous |  Page 1458: Articles 14571-14580  | Next

Automated, miniaturized, and scalable screening of healthcare workers, first responders, and students for SARS-CoV-2 in San Diego County
Morgan, S. C., Aigner, S., Anderson, C., Belda-Ferre, P., De Hoff, P., Marotz, C. A., Sathe, S., Zeller, M., Ahmed, N., Audhya, X., Baer, N. A., Barber, T., Barrick, B., Batachari, L., Betty, M., Blue, S. M., Brainard, B., Buckley, T., Case, J., Castro-Martinez, A., Chacon, M., Cheung, W., Chong, L., Coufal, N. G., Crescini, E. S., DeGrand, S., Dimmock, D. P., Donofrio-Odmann, J. J., Eisner, E. R., Estaki, M., Franco Vargas, L., Freddock, M., Gallant, R. M., Galmozzi, A., Gao, N. J., Gilmer, S., Grzelak, E. M., Hakim, A., Hart, J., Hobbs, C., Humphrey, G., Ilkenhans, N., Jacobs, M., Kahn, C. A., Kapadia, B. K., Kim, M., Kurian, S., Lastrella, A. L., Lawrence, E. S., Lee, K., Liang, Q., Liliom, H., Lo Sardo, V., Logan, R., Machnicki, M., Magallanes, C. G., Mah, C. K., Malacki, D., Marina, R. J., Marsh, C., Martin, N. K., Matteson, N. L., Maunder, D. J., McBride, K., McDonald, B., McGraw, M., Meadows, A. R., Meyer, M., Morey, A. L., Mueller, J. R., Ngo, T. T., Nguyen, J., Nguyen, V., Nicholson, L. J., Nouri, A., Nudell, V., Nunez, E., O'Neill, K., Ostrander, R. T., Pantham, P., Park, S. S., Picone, D., Plascencia, A., Pratumchai, I., Quigley, M., Ragsac, M. F., Richardson, A. C., Robles-Sikisaka, R., Ruiz, C. A., Ryan, J., Sacco, L., Saraf, S., Seaver, P., Sewall, L., Smoot, E. W., Sweeney, K. M., Tekkatte, C., Tsai, R., Valentine, H., Walsh, S., Williams, A., Wu, M. Y., Xia, B., Yee, B., Zhang, J. Z., Andersen, K. G., Farnaes, L., Knight, R., Yeo, G. W., Laurent, L. C.
10.1101/2021.06.25.21257885 — Posted: 2021-06-28
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men
Stirrup, O., Boshier, F. A. T., Venturini, C., Guerra-Assuncao, J., Alcolea-Medina, A., Becket, A. H., Charalampous, T., da Silva Filipe, A., Glaysher, S., Khan, T., Kulasegara-Shylini, R., Kele, B., Monahan, I. M., Mollett, G., Parker, M., Pelosi, E., Randell, P., Roy, S., Taylor, J. F., Weller, S. J., Wilson-Davies, E., Wade, P., Williams, R., COG-UK HOCI Variant Substudy consortium, , The COVID-19 Genomics UK (COG-UK) consortium, , Copas, A. J., Cutino-Moguel, T., Freemantle, N., Hayward, A. C., Holmes, A., Hughes, J., Mahungu, T. W., Nebbia, G., Partridge, D. G., Pope, C. F., Price, J. R., Robson, S. C., Saeed, K., de Silva, T. I., Snell, L. B., Thomson, E. C., Witney, A. A., Breuer, J.
10.1101/2021.06.24.21259107 — Posted: 2021-06-28
Macro-Level Drivers of SARS-CoV-2 Transmission: A Data-Driven Analysis of Factors Contributing to Epidemic Growth During the First Wave of outbreaks in the United States
Watts, M.
10.1101/2021.06.23.21259394 — Posted: 2021-06-28
Pre-activated anti-viral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
Loske, J., Röhmel, J., Lukassen, S., Stricker, S., Magalhaes, V. G., Liebig, J., Chua, R. L., Thürmann, L., Messingschlager, M., Seegebarth, A., Timmermann, B., Klages, S., Ralser, M., Sawitzki, B., Sander, L. E., Corman, V. M., Conrad, C., Laudi, S., Binder, M., Trump, S., Eils, R., Mall, M., Lehmann, I.
10.1101/2021.06.24.21259087 — Posted: 2021-06-28
Short-term Outcomes in Children Recovered from Multisystem Inflammatory Syndrome associated with SARS-CoV-2 infection
Patnaik, S., Jain, M. K., Ahmed, S., Dash, A. K., P, R. K., Sahoo, B., Mishra, R., Behera, M. R.
10.1101/2021.06.23.21259292 — Posted: 2021-06-28
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
Davis, C., Logan, N., Tyson, G., Orton, R., Harvey, W., Haughney, J., Perkins, J., The COVID-19 Genomics UK (COG-UK) Consortium, , Peacock, T., Barclay, W. S., Cherepanov, P., Palmarini, M., Murcia, P. R., Patel, A. H., Robertson, D. L., Thomson, E. C., Willett, B. J.
10.1101/2021.06.23.21259327 — Posted: 2021-06-28
C Reactive Protein based early intervention for home quarantined COVID-19 patients to avoid complications and hospitalization.
Arjunan, M., U.R, A., Verma, K., Manimarane, O.
10.1101/2021.06.22.21258712 — Posted: 2021-06-28
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19
Agrati, C., Capone, S., Castilletti, C., Cimini, E., Matusali, G., Meschi, S., Tartaglia, E., Camerini, R., Lanini, S., Milleri, S., Colloca, S., Vitelli, A., Folgori, A.
10.1101/2021.06.22.21258961 — Posted: 2021-06-28
Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review
Saadi, N., Chi, Y.-L., Ghosh, S., Eggo, R. M., McCarthy, C., Quaife, M., Dawa, J., Jit, M., Vassall, A.
10.1101/2021.06.21.21259104 — Posted: 2021-06-28
Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalization among Finnish elderly and chronically ill - An interim analysis of a nationwide cohort study
Baum, U., Poukka, E. J., Palmu, A., Salo, H., Lehtonen, T. O., Leino, T.
10.1101/2021.06.21.21258686 — Posted: 2021-06-28 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).